tetano
Editor, Senior Moderator
Rev Clin Esp (Barc)
. 2022 Jan;222(1):37-41.
doi: 10.1016/j.rceng.2020.10.006. Epub 2021 Apr 30.
CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study
J Carriel[SUP] 1 [/SUP], R Muñoz-Jaramillo[SUP] 2 [/SUP], O Bolaños-Ladinez[SUP] 3 [/SUP], F Heredia-Villacreses[SUP] 3 [/SUP], J Menéndez-Sanchón[SUP] 4 [/SUP], J Martin-Delgado[SUP] 5 [/SUP], COVID-EC Researh Group
Affiliations
Abstract
Objective: This article aims to assess the utility of CURB-65 in predicting 30-day mortality in adult patients hospitalized with COVID-19.
Methods: This work is a cohort study conducted between March 1 and April 30, 2020 in Ecuador.
Results: A total of 247 patients were included (mean age 60 ± 14 years, 70% men, overall mortality 41.3%). Patients with CURB-65 ≥ 2 had a higher mortality rate (57 vs. 17%, p < .001) that was associated with other markers of risk: advanced age, hypertension, overweight/obesity, kidney failure, hypoxemia, requirement for mechanical ventilation, or onset of respiratory distress.
Conclusions: CURB-65 ≥ 2 was associated with higher 30-day mortality on the univariate (Kaplan-Meier estimator) and multivariate (Cox regression) analysis.
Keywords: COVID-19; CURB-65; Coronavirus; Mortalidad; Mortality; Neumonía; Pneumonia; SARS-CoV-2.
. 2022 Jan;222(1):37-41.
doi: 10.1016/j.rceng.2020.10.006. Epub 2021 Apr 30.
CURB-65 as a predictor of 30-day mortality in patients hospitalized with COVID-19 in Ecuador: COVID-EC study
J Carriel[SUP] 1 [/SUP], R Muñoz-Jaramillo[SUP] 2 [/SUP], O Bolaños-Ladinez[SUP] 3 [/SUP], F Heredia-Villacreses[SUP] 3 [/SUP], J Menéndez-Sanchón[SUP] 4 [/SUP], J Martin-Delgado[SUP] 5 [/SUP], COVID-EC Researh Group
Affiliations
- PMID: 34996587
- DOI: 10.1016/j.rceng.2020.10.006
Abstract
Objective: This article aims to assess the utility of CURB-65 in predicting 30-day mortality in adult patients hospitalized with COVID-19.
Methods: This work is a cohort study conducted between March 1 and April 30, 2020 in Ecuador.
Results: A total of 247 patients were included (mean age 60 ± 14 years, 70% men, overall mortality 41.3%). Patients with CURB-65 ≥ 2 had a higher mortality rate (57 vs. 17%, p < .001) that was associated with other markers of risk: advanced age, hypertension, overweight/obesity, kidney failure, hypoxemia, requirement for mechanical ventilation, or onset of respiratory distress.
Conclusions: CURB-65 ≥ 2 was associated with higher 30-day mortality on the univariate (Kaplan-Meier estimator) and multivariate (Cox regression) analysis.
Keywords: COVID-19; CURB-65; Coronavirus; Mortalidad; Mortality; Neumonía; Pneumonia; SARS-CoV-2.